CoChat
Sign Up
Cited by 91

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study

Toh, Sengwee, Hampp, Christian, Reichman, Marsha E., Graham, David J., Balakrishnan, Suchitra, Pucino, Frank, Hamilton, Jack, Lendle, Samuel, Iyer, Aarthi, Rucker, Malcolm, Pimentel, Madelyn, Nathwani, Neesha, Griffin, Marie R., Brown, Nancy J., Fireman, Bruce H.·2016·Annals of Internal Medicine
DOI 10.7326/m15-2568PMC PMC5178978
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m15-2568

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Saxagliptin has raised concerns regarding potential increased risks of heart failure.

    “This contrasts with saxagliptin, another dipeptidyl peptidase-4 inhibitor, which has raised concerns regarding potential increased risks of heart failure, and linagliptin, which is commonly prescribed for patients with kidney impairment, and thus could lead to increased confounding in contrast to our comparator sitagliptin.20-25”

    From Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction (2025) · cites this paper as [23]

  • Linagliptin is commonly prescribed for patients with kidney impairment, which could lead to increased confounding in contrast to sitagliptin.

    “This contrasts with saxagliptin, another dipeptidyl peptidase-4 inhibitor, which has raised concerns regarding potential increased risks of heart failure, and linagliptin, which is commonly prescribed for patients with kidney impairment, and thus could lead to increased confounding in contrast to our comparator sitagliptin.20-25”

    From Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction (2025) · cites this paper as [23]

    The Discussion mentions linagliptin only when reporting a heart-failure odds ratio from a meta-analysis; it does not discuss prescribing linagliptin to patients with kidney impairment. Although the Abstract lists residual confounding as a limitation, our copy does not link it to linagliptin or compare it with sitagliptin on that basis (searched: linagliptin, kidney impairment, renal prescribing, confounding). (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. 10.1111/j.1463-1326.2010.01306.x · DOI
  2. 10.1056/NEJMoa1307684 · DOI · Paper page
  3. 10.1016/S0140-6736(14)62225-X · DOI · Paper page
  4. 10.1136/hrt.2009.183624 · DOI
  5. 10.1016/S2213-8587(14)70031-2 · DOI
  6. 10.1002/pds.2337 · DOI
  7. 10.1093/aje/kwg231 · DOI · Paper page
  8. 10.4158/EP.15.6.540 · DOI · Paper page
  9. 10.1056/NEJMp1014427 · DOI
  10. 10.1002/pds.2343 · DOI
  11. 10.1002/pds.2336 · DOI
  12. 10.1002/pds.2319 · DOI
  13. 10.1002/pds.2313 · DOI
  14. 10.1002/pds.3231 · DOI
  15. 10.1002/pds.1926 · DOI · Paper page
  16. 10.1056/NEJMp1401664 · DOI
  17. 10.1016/S0140-6736(07)61514-1 · DOI · Paper page
  18. 10.2337/diacare.27.8.1879 · DOI · Paper page
  19. 10.1016/j.ejheart.2008.05.013 · DOI
  20. 10.1016/0002-9149(74)90089-7 · DOI · Paper page
  21. 10.1016/j.numecd.2014.01.017 · DOI
  22. 10.1111/1755-5922.12075 · DOI
  23. 10.1016/j.jchf.2014.04.005 · DOI
  24. 10.1016/j.ijcard.2014.12.029 · DOI
  25. 10.1007/s00592-014-0663-2 · DOI
  26. 10.2337/dc15-0764 · DOI
  27. 10.2337/dc14-1459 · DOI
  28. 10.1002/pds.1200 · DOI

Cited by

Sorted by citations

Metadata

Authors
Toh, S., Hampp, C., Reichman, M. E., Graham, D. J., Balakrishnan, S., Pucino, F., Hamilton, J., Lendle, S., Iyer, A., Rucker, M., Pimentel, M., Nathwani, N., Griffin, M. R., Brown, N. J., & Fireman, B. H.
Affiliations
From Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; U.S. Food and Drug Administration, Silver Spring, Maryland; Vanderbilt University and VA Tennessee Valley Health Care System, Nashville, Tennessee; and Kaiser Permanente Northern California, Oakland, California.
Venue
Annals of Internal Medicine
Publisher
American College of Physicians
Published
2016-06-07
Volume
164
Issue
11
Pages
705-714
ISSN
  • 0003-4819
  • 1539-3704
DOI
10.7326/m15-2568
PMC
PMC5178978
Cited by
91
References
2
Language
en
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review